Written by : Jayati Dubey
September 28, 2023
With the recent Series-B funding round led by Creaegis, Doceree plans to accelerate its product development efforts, expand its global reach, and strengthen its team.
Physician engagement startup Doceree has secured $35 million in a Series-B funding round led by Creaegis. The funding will be utilised to enhance product development, scale global expansion, and augment technologies.'¯
Doceree, founded in 2019 by Harshit Jain, Daleep Manhas, Michael Fishweicher and Stephen Hoelper, headquartered in New York, is an integrated programmatic adexchange for data-driven marketing exclusively to physicians and point of care (EMR/EHR) platforms.
Doceree aims to bridge the gap between pharmaceutical companies, life sciences firms, and healthcare professionals by providing innovative solutions that facilitate effective communication and engagement.'¯
By leveraging their networks and digital workflows, Doceree enables healthcare professionals to access relevant information and resources that enhance patient care.
Doceree Enterprise and Doceree Provider. This first solution focuses on healthcare professional (HCP)-focused global Demand Side Platforms (DSPs). It allows life science marketers to engage with physicians effectively and provides them with customised solutions to meet their specific needs.
Doceree Provider, on the other hand, helps healthcare professionals to improve the health outcomes of their patients. The startup said, by leveraging Doceree Provider, physicians can access relevant information, resources, and tools to enhance patient care and treatment strategies.
With the recent capital infusion, Doceree plans to accelerate its product development efforts, expand its global reach, and strengthen its team. Prior to the Series-B funding round, Doceree raised $11 million in a Series-A funding round led by Eight Roads Ventures.'¯
Doceree operates through 21 countries, with a strong presence in the United States. As per the startup, about 80% of Doceree's revenues is generated from the US market, where they work with eight out of the top 10 pharmaceutical companies.'¯
The startup has offices in New Jersey, London, and New Delhi and has expanded its business to regions such as Africa, Southeast Asia, and the Gulf Cooperation Council.
Creaegis, on the other hand, invests in global software-as-a-service (SaaS) companies and the healthcare ecosystem.
Despite recent sluggishness in funding for the healthtech sector, MediBuddy, a Bengaluru-based digital healthcare startup, recently bagged an additional $18 million funding from existing investors such as Quadria Capital, Lightrock, and TEAMFund. This achievement comes on the heels of a significant $125 million raised during its Series-C funding round in February 2022.
In a similar vein, LISSUN, a Gurugram-based mental health platform, recently closed a seed funding round of $1.3 million, with leading investments from Inflection Point Ventures (IPV) and Rainmatter Capital, a part of the Zerodha Group. The startup's statement indicates that LISSUN has now amassed over $2.3 million in total funding.
As per the startup, it offers two primary solutions to facilitate physician engagement: